Cannara Biotech Inc. (LOVE.V)

CAD 0.68

(0.0%)

Operating Expenses Summary of Cannara Biotech Inc.

  • Cannara Biotech Inc.'s latest annual operating expenses in 2023 was 15.34 Million CAD , up 23.1% from previous year.
  • Cannara Biotech Inc.'s latest quarterly operating expenses in 2024 Q3 was 5.2 Million CAD , down -44.19% from previous quarter.
  • Cannara Biotech Inc. reported a annual operating expenses of 12.35 Million CAD in annual operating expenses 2022, up 23.59% from previous year.
  • Cannara Biotech Inc. reported a annual operating expenses of 9.99 Million CAD in annual operating expenses 2021, down -24.0% from previous year.
  • Cannara Biotech Inc. reported a quarterly operating expenses of 4.79 Million CAD for 2024 Q1, up 19.91% from previous quarter.
  • Cannara Biotech Inc. reported a quarterly operating expenses of 5.2 Million CAD for 2024 Q3, down -44.19% from previous quarter.

Annual Operating Expenses Chart of Cannara Biotech Inc. (2023 - 2018)

Historical Annual Operating Expenses of Cannara Biotech Inc. (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 15.34 Million CAD 23.1%
2022 12.35 Million CAD 23.59%
2021 9.99 Million CAD -24.0%
2020 13.15 Million CAD 10.38%
2019 11.91 Million CAD 502.99%
2018 1.97 Million CAD 0.0%

Peer Operating Expenses Comparison of Cannara Biotech Inc.

Name Operating Expenses Operating Expenses Difference
Aequus Pharmaceuticals Inc. 2.96 Million CAD -417.652%
CanadaBis Capital Inc. 7.1 Million CAD -115.891%
Decibel Cannabis Company Inc. 40.44 Million CAD 62.067%
Delivra Health Brands Inc. 7.1 Million CAD -115.824%
Entourage Health Corp. 3.7 Million CAD -313.813%
Lifeist Wellness Inc. 17.59 Million CAD 12.796%
Medicure Inc. 13.98 Million CAD -9.679%
PharmaCielo Ltd. 8.33 Million CAD -84.142%
Rubicon Organics Inc. 14.22 Million CAD -7.865%
BioSyent Inc. 17.6 Million CAD 12.866%
Voyageur Pharmaceuticals Ltd. 1.22 Million CAD -1156.637%